Amit J Sabnis

5PUBLICATIONS

60CO-AUTHORS

Solid tumoursMolecular targetsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Oct 14, 2026

PAX3::FOXO1 and the INO80 complex sustain replication fork progression in fusion positive rhabdomyosarcoma.

|Jun 27, 2024

Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.

Kieuhoa T Vo, Amit J Sabnis, P Mickey Williams

|Mar 30, 2023

Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma.

Amanda E Marinoff, Liam F Spurr, Christina Fong

|Nov 29, 2022

Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer.

Lorena Lazo De La Vega, Hannah Comeau, Sarah Sallan

|Sep 01, 2018

Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway.

L J Bugaj, A J Sabnis, A Mitchell

Pageof 1

Frequent Collaborators

Katherine A Janeway

Suzanne J Forrest

Navin R Pinto

Margaret E Macy

Luke Maese

L J Bugaj

A Mitchell

J E Toettcher

E Alejandro Sweet-Cordero

1 joint publications

Lorena Lazo De La Vega

Frequent Collaborators

Katherine A Janeway

Suzanne J Forrest

Navin R Pinto

Margaret E Macy